ITGA2 and hepatitis C virus infection: The findings of this study show for the first time that serum Tr1 gene expression levels, assessed from the expression of the surface marker CD49b before the introduction of antiviral therapy, were predictive of an SVR in patients with recurrent hepatitis C after LT.